The causal relationship between serum bile acids and gastric cancer: evidence based on regression discontinuity design.
- Author:
Yan WANG
1
;
Songbo LI
2
;
Zheyi HAN
3
,
4
Author Information
1. Department of Gastroenterology and Endoscopy Center, The 986th Hospital of PLAAF, Xi'an 710054, China.
2. Department of Gastroenterology, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
3. Department of Gastroenterology, Air Force Medical Center, Beijing 100142, China. *Corresponding author, E-mail: zheyihan_fmmu@
4. com.
- Publication Type:Journal Article
- MeSH:
Humans;
Stomach Neoplasms/etiology*;
Male;
Female;
Middle Aged;
Bile Acids and Salts/blood*;
Aged;
Adult;
Risk Factors;
Case-Control Studies;
Biomarkers, Tumor/blood*;
Logistic Models
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(6):531-535
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the causal relationship between serum total bile acid (TBA) levels and gastric cancer (GC) using regression discontinuity design (RDD). Methods A total of 1244 GC patients and 1333 healthy controls were included in the study. Demographic characteristics, gallbladder disease history, tumor markers, and serum TBA levels were collected from both groups. Logistic regression was used to construct a risk prediction model to estimate the risk of GC. RDD was employed with serum TBA as the grouping variable and the individual risk of developing GC as the outcome variable. Results The predictive factors in the GC risk prediction model included age, sex, body mass index(BMI), serum TBA, carcinoembryoniv antigen(CEA), alpha fetoprotein(AFP), carbohydrate antigen 199(CA199), and CA125. Serum TBA was identified as an independent risk factor for GC (OR=1.054, 95% CI: 1.030 to 1.079). RDD analysis indicated that when serum TBA levels reached 8 μmol/L, the probability of developing GC increased sharply by 23.7%. The breakpoint remained statistically significant following validity and robustness assessments. Conclusion The study demonstrates a positive causal relationship between serum TBA levels and GC, when the serum TBA level reaches 8 μmol/L, the risk of an individual developing GC increases sharply.
